Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080910 | SCV000112817 | benign | not specified | 2012-11-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080910 | SCV000310141 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000080910 | SCV000519257 | benign | not specified | 2016-06-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002055182 | SCV002405044 | benign | Bethlem myopathy 1A | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004710482 | SCV005261840 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000080910 | SCV001925194 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000080910 | SCV001957751 | benign | not specified | no assertion criteria provided | clinical testing |